Electra Therapeutics, Inc. ETRA
9.45 USD +1.46 (+18.27%)
At closeNov 11, 2026, 4:00 PM EST
9.45 0.00 0.00%
After hours · Nov 11, 4:00 PM ET
8.18 Day range 9.49
6.87 52-week range 15.50
- YTD
- -28.68%
- 1 year
- -28.68%
News
defenseworld.net Electra Therapeutics (NASDAQ:ETRA) Stock: Insider Orbimed Advisors Llc Buys 245,113 Shares Electra Therapeutics, Inc. (NASDAQ: ETRA - Get Free Report) Director Orbimed Advisors Llc purchased 245,113 shares of the firm's stock in a transaction on Tuesday, November 3rd. The stock was bought…
defenseworld.net Electra Therapeutics (NASDAQ:ETRA) Stock: Insider Carl Gordon Purchases 245,113 Shares Electra Therapeutics, Inc. (NASDAQ: ETRA - Get Free Report) Director Carl Gordon acquired 245,113 shares of the company's stock in a transaction that occurred on Tuesday, November 3rd. The shares…
defenseworld.net Electra Therapeutics (NASDAQ:ETRA) Stock: Insider Carl Gordon Purchases 245,113 Shares Electra Therapeutics, Inc. (NASDAQ: ETRA - Get Free Report) Director Carl Gordon acquired 245,113 shares of the company's stock in a transaction that occurred on Tuesday, November 3rd. The shares…
defenseworld.net Electra Therapeutics (NASDAQ:ETRA) Stock: Insider Orbimed Advisors Llc Buys 245,113 Shares Electra Therapeutics, Inc. (NASDAQ: ETRA - Get Free Report) Director Orbimed Advisors Llc purchased 245,113 shares of the firm's stock in a transaction on Tuesday, November 3rd. The stock was bought…
globenewswire.com Electra Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference in London SOUTH SAN FRANCISCO, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Electra Therapeutics, Inc. (NASDAQ: ETRA) a late clinical-stage biopharmaceutical company focused on pioneering a new class of precision…
benzinga.com This FirstEnergy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday Analysts initiated coverage on FE, ACCV, XE and ETRA, issuing Buy, Outperform, Equal-Weight and Hold ratings with targets up to $50.
benzinga.com HC Wainwright & Co. Initiates Coverage On Electra Therapeutics with Buy Rating, Announces Price Target of $30 HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on Electra Therapeutics (NASDAQ:ETRA) with a Buy rating and announces Price Target of $30.
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers Lucid Diagnostics (NASDAQ:LUCD) stock moved upwards by 29.7% to $0.42 during Friday's pre-market session. The company's market cap stands at $63.6 million. Electra Therapeutics (NASDAQ:ETRA)…
benzinga.com Star Therapeutics Announces $200M Private Financing To Support Its Pipeline Of Potential Best-in-Disease Therapies The financing follows the July 2026 acquisition of Star subsidiary Vega Therapeutics and was co-led by OrbiMed and Janus Henderson Investors, with participation from Agent Capital, Catalio Capital…- benzinga.com JP Morgan Initiates Coverage On Electra Therapeutics with Overweight Rating, Announces Price Target of $36 JP Morgan analyst Anupam Rama initiates coverage on Electra Therapeutics (NASDAQ:ETRA) with a Overweight rating and announces Price Target of $36.
benzinga.com Jefferies Initiates Coverage On Electra Therapeutics with Buy Rating, Announces Price Target of $32 Jefferies analyst Akash Tewari initiates coverage on Electra Therapeutics (NASDAQ:ETRA) with a Buy rating and announces Price Target of $32.
benzinga.com Evercore ISI Group Initiates Coverage On Electra Therapeutics with Outperform Rating, Announces Price Target of $36 Evercore ISI Group initiates coverage on Electra Therapeutics (NASDAQ:ETRA) with a Outperform rating and announces Price Target of $36.
benzinga.com This Electra Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday Analysts initiated coverage on NHP (Outperform, $20), OIG (Buy, $13), ETRA (Overweight), AHR (Strong Buy, $62).
benzinga.com Cantor Fitzgerald Initiates Coverage On Electra Therapeutics with Overweight Rating Cantor Fitzgerald analyst Eric Schmidt initiates coverage on Electra Therapeutics (NASDAQ:ETRA) with a Overweight rating.
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers NewGenIvf Group (NASDAQ:NIVF) shares moved upwards by 106.0% to $0.15 during Wednesday's pre-market session. Connect Biopharma Hldgs (NASDAQ:CNTB) stock increased by 79.43% to $1.78. The…
defenseworld.net Electra Therapeutics (NASDAQ:ETRA) Director Carl Gordon Acquires 1,333,333 Shares of Stock Electra Therapeutics, Inc. (NASDAQ: ETRA - Get Free Report) Director Carl Gordon bought 1,333,333 shares of the company's stock in a transaction that occurred on Monday, September 21st. The stock was…
defenseworld.net Electra Therapeutics (NASDAQ:ETRA) Director Orbimed Advisors Llc Purchases 1,333,333 Shares Electra Therapeutics, Inc. (NASDAQ: ETRA - Get Free Report) Director Orbimed Advisors Llc bought 1,333,333 shares of the business's stock in a transaction on Monday, September 21st. The shares were…
globenewswire.com Kinzey Capital Management: Electra Sets Nasdaq IPO Terms Kinzey Capital Management, based in Singapore, runs discretionary multi-asset portfolios serving private clients, corporates, families and foundations.
globenewswire.com Electra Therapeutics Announces Pricing of Upsized $350.0 Million Initial Public Offering SOUTH SAN FRANCISCO, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Electra Therapeutics, Inc., a late clinical-stage biopharmaceutical company focused on pioneering a new class of precision medicines…
reuters.com Electra Therapeutics targets $977.6 million valuation in US IPO Drug developer Electra Therapeutics is targeting a valuation of up to $977.6 million in its U.S. initial public offering, according to a filing on Monday, extending a comeback in biotech listings…